HomeCompareCATF vs JNJ

CATF vs JNJ: Dividend Comparison 2026

CATF yields 3.52% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CATF wins by $5.1K in total portfolio value
10 years
CATF
CATF
● Live price
3.52%
Share price
$49.72
Annual div
$1.75
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$440.79
Full CATF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CATF vs JNJ

📍 CATF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCATFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CATF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CATF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CATF
Annual income on $10K today (after 15% tax)
$298.85/yr
After 10yr DRIP, annual income (after tax)
$374.67/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $328.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CATF + JNJ for your $10,000?

CATF: 50%JNJ: 50%
100% JNJ50/50100% CATF
Portfolio after 10yr
$22.6K
Annual income
$634.28/yr
Blended yield
2.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CATF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CATF buys
0
JNJ buys
0
No recent congressional trades found for CATF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCATFJNJ
Forward yield3.52%3.36%
Annual dividend / share$1.75$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$25.1K$20.0K
Annual income after 10y$440.79$827.78
Total dividends collected$4.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CATF vs JNJ ($10,000, DRIP)

YearCATF PortfolioCATF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,052$351.58$10,676$355.77+$376.00CATF
2$12,188$363.14$11,407$389.39+$781.00CATF
3$13,416$374.29$12,198$426.53+$1.2KCATF
4$14,740$385.03$13,056$467.62+$1.7KCATF
5$16,167$395.36$13,987$513.12+$2.2KCATF
6$17,704$405.27$14,998$563.56+$2.7KCATF
7$19,358$414.76$16,098$619.52+$3.3KCATF
8$21,137$423.84$17,295$681.69+$3.8KCATF
9$23,049$432.52$18,599$750.82+$4.5KCATF
10$25,103$440.79$20,022$827.78+$5.1KCATF

CATF vs JNJ: Complete Analysis 2026

CATFStock

Seeks high current income that is exempt from federal and California income tax.

Full CATF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CATF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CATF vs SCHDCATF vs JEPICATF vs OCATF vs KOCATF vs MAINCATF vs ABBVCATF vs MRKCATF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.